NO153370C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter.

Info

Publication number
NO153370C
NO153370C NO822863A NO822863A NO153370C NO 153370 C NO153370 C NO 153370C NO 822863 A NO822863 A NO 822863A NO 822863 A NO822863 A NO 822863A NO 153370 C NO153370 C NO 153370C
Authority
NO
Norway
Prior art keywords
adenosylmethionists
stable
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO822863A
Other languages
English (en)
Norwegian (no)
Other versions
NO822863L (no
NO153370B (no
Inventor
Federico Gennari
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO153370(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Publication of NO822863L publication Critical patent/NO822863L/no
Publication of NO153370B publication Critical patent/NO153370B/no
Publication of NO153370C publication Critical patent/NO153370C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
NO822863A 1981-08-24 1982-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter. NO153370C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23603/81A IT1137892B (it) 1981-08-24 1981-08-24 Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Publications (3)

Publication Number Publication Date
NO822863L NO822863L (no) 1983-02-25
NO153370B NO153370B (no) 1985-11-25
NO153370C true NO153370C (no) 1986-03-05

Family

ID=11208488

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822863A NO153370C (no) 1981-08-24 1982-08-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter.

Country Status (23)

Country Link
US (1) US4543408A (it)
EP (1) EP0073376B2 (it)
JP (1) JPS5843995A (it)
AR (1) AR231453A1 (it)
AT (1) ATE16394T1 (it)
AU (1) AU552466B2 (it)
CA (1) CA1201434A (it)
CZ (1) CZ279834B6 (it)
DD (1) DD210455A1 (it)
DE (1) DE3267295D1 (it)
DK (1) DK149861C (it)
ES (1) ES515191A0 (it)
FI (1) FI72525C (it)
GR (1) GR76862B (it)
HU (1) HU186108B (it)
IL (1) IL66584A0 (it)
IT (1) IT1137892B (it)
NO (1) NO153370C (it)
NZ (1) NZ201679A (it)
PL (1) PL137816B1 (it)
PT (1) PT75454B (it)
YU (1) YU42793B (it)
ZA (1) ZA825971B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1169772B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
JPS6279792A (ja) * 1985-10-04 1987-04-13 Showa Sangyo Kk 注射用原料結晶ぶどう糖の製造方法
FR2623396B1 (fr) * 1987-11-25 1990-03-30 Sanofi Sa Utilisation de l'ademetionine contre le vieillissement de la peau
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
IT1317920B1 (it) * 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US6649753B2 (en) 2001-06-07 2003-11-18 Orchid Chemicals & Pharmaceuticals Ltd. Stable salts of S-adenosyl-L-methionine (SAMe) and the process for their preparation
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
EP2017331B1 (en) 2006-05-16 2015-04-01 Mitsubishi Gas Chemical Company, Inc. Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability
KR101525263B1 (ko) 2007-01-25 2015-06-10 미츠비시 가스 가가쿠 가부시키가이샤 보존 안정성이 뛰어난 ｓ-아데노실-ｌ-메티오닌 함유 건조 효모의 제조 방법, 그 제조물 및 그 성형된 조성물
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
CN101481660B (zh) * 2009-01-20 2011-02-09 中国药科大学 一株高产腺苷蛋氨酸的菌种
WO2014113609A1 (en) 2013-01-16 2014-07-24 Hebert Sam-E Llc Stable indole-3-propionate salts of s-adenosyl-l-methionine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2969353A (en) * 1957-02-06 1961-01-24 Merck & Co Inc Process for the preparation of "active methionine" and products obtained thereby
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
JPS5320998B2 (it) * 1974-06-13 1978-06-29
FR2275220A1 (fr) * 1974-06-21 1976-01-16 Merieux Inst Procede d'obtention de sels organiques de la s.adenosyl-l-methionine. nouveaux sels organiques obtenus des medicaments comprenant un ou plusieurs nouveaux sels obtenus
JPS516989A (en) * 1974-07-05 1976-01-20 Yamasa Shoyu Kk Ss adenoshiru ll echioninno seiseiho
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
GB2001976B (en) * 1977-08-03 1982-03-10 Yamasa Shoyu Kk S-adenosyl-l-methionine compositions and production thereof
JPS5619879A (en) * 1979-07-25 1981-02-24 Showa Electric Wire & Cable Co Method of molding cable connector
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
JPS57192399A (en) * 1981-05-18 1982-11-26 Kanegafuchi Chem Ind Co Ltd Composition containing s-adenosyl-l-methionine and its preparation

Also Published As

Publication number Publication date
EP0073376B1 (en) 1985-11-06
AU8740582A (en) 1983-03-03
PT75454A (en) 1982-09-01
CA1201434A (en) 1986-03-04
HU186108B (en) 1985-06-28
ZA825971B (en) 1983-06-29
FI822944L (fi) 1983-02-25
FI72525C (fi) 1987-06-08
ATE16394T1 (de) 1985-11-15
NZ201679A (en) 1986-04-11
ES8306371A1 (es) 1983-06-01
PT75454B (en) 1984-11-19
FI822944A0 (fi) 1982-08-24
IT1137892B (it) 1986-09-10
PL238024A1 (en) 1983-05-09
DK149861C (da) 1987-03-02
EP0073376A1 (en) 1983-03-09
GR76862B (it) 1984-09-04
DK149861B (da) 1986-10-13
DE3267295D1 (en) 1985-12-12
YU42793B (en) 1988-12-31
CZ614282A3 (en) 1995-04-12
IT8123603A0 (it) 1981-08-24
YU190882A (en) 1985-04-30
NO822863L (no) 1983-02-25
JPH0149274B2 (it) 1989-10-24
NO153370B (no) 1985-11-25
CZ279834B6 (cs) 1995-07-12
PL137816B1 (en) 1986-07-31
ES515191A0 (es) 1983-06-01
AU552466B2 (en) 1986-06-05
JPS5843995A (ja) 1983-03-14
US4543408A (en) 1985-09-24
EP0073376B2 (en) 1989-07-26
AR231453A1 (es) 1984-11-30
FI72525B (fi) 1987-02-27
DK377282A (da) 1983-02-25
IL66584A0 (en) 1982-12-31
DD210455A1 (de) 1984-06-13

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO153370C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO164472C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO157421C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3,7-diazabicyclo-(3.3.1)-nonan-derivater.